Shu-Yuan Yeh
Concepts (393)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Receptors, Androgen | 61 | 1994 | 29 |
Why?
| Prostatic Neoplasms | 43 | 1996 | 120 |
Why?
| Vitamin E | 10 | 2002 | 38 |
Why?
| Trans-Activators | 22 | 1996 | 113 |
Why?
| Oncogene Proteins | 18 | 1996 | 26 |
Why?
| Prostate | 14 | 1994 | 55 |
Why?
| Transcriptional Activation | 25 | 1998 | 99 |
Why?
| Transcription Factors | 22 | 1996 | 201 |
Why?
| Carrier Proteins | 11 | 1999 | 177 |
Why?
| Gene Expression Regulation, Neoplastic | 8 | 1998 | 126 |
Why?
| Estrogen Receptor alpha | 4 | 2008 | 20 |
Why?
| Cell Line, Tumor | 19 | 2003 | 208 |
Why?
| Tocopherols | 8 | 2002 | 9 |
Why?
| Lipoproteins | 3 | 2005 | 52 |
Why?
| Male | 74 | 1994 | 1553 |
Why?
| Mice | 40 | 1994 | 623 |
Why?
| Androgens | 10 | 1998 | 38 |
Why?
| Spermatogenesis | 6 | 2002 | 14 |
Why?
| Testis | 11 | 1994 | 54 |
Why?
| Stromal Cells | 6 | 2005 | 41 |
Why?
| Cell Division | 8 | 1999 | 273 |
Why?
| Testosterone | 10 | 1996 | 57 |
Why?
| Animals | 55 | 1994 | 1031 |
Why?
| Mice, Knockout | 21 | 2002 | 265 |
Why?
| Tumor Suppressor Proteins | 3 | 2008 | 51 |
Why?
| Apoptosis | 15 | 2001 | 265 |
Why?
| Antioxidants | 2 | 2002 | 84 |
Why?
| Intracellular Signaling Peptides and Proteins | 9 | 1999 | 73 |
Why?
| Nuclear Receptor Coactivators | 18 | 1996 | 6 |
Why?
| Tumor Cells, Cultured | 22 | 1996 | 233 |
Why?
| Humans | 65 | 1994 | 1856 |
Why?
| Receptors, Estrogen | 7 | 1998 | 44 |
Why?
| Flutamide | 8 | 1996 | 10 |
Why?
| Insulin-Like Growth Factor I | 2 | 2003 | 64 |
Why?
| Antineoplastic Agents | 3 | 2007 | 190 |
Why?
| Retinoblastoma Protein | 3 | 1998 | 26 |
Why?
| alpha-Tocopherol | 2 | 2007 | 5 |
Why?
| Carcinoma | 2 | 2009 | 109 |
Why?
| Transcription, Genetic | 8 | 1996 | 253 |
Why?
| Prostate-Specific Antigen | 5 | 1997 | 34 |
Why?
| Androgen Antagonists | 7 | 1997 | 18 |
Why?
| Cell Proliferation | 12 | 2004 | 227 |
Why?
| Mice, Nude | 7 | 2004 | 72 |
Why?
| Muscle, Smooth | 1 | 2010 | 69 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2004 | 243 |
Why?
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2009 | 19 |
Why?
| Infertility, Male | 3 | 2004 | 19 |
Why?
| Estrogen Receptor beta | 1 | 2009 | 10 |
Why?
| Sertoli Cells | 3 | 2004 | 10 |
Why?
| Neoplasm Invasiveness | 3 | 2004 | 105 |
Why?
| Epithelial Cells | 6 | 2007 | 135 |
Why?
| Cell Cycle | 4 | 1998 | 121 |
Why?
| Calcitriol | 1 | 2009 | 29 |
Why?
| Signal Transduction | 12 | 1999 | 313 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 16 |
Why?
| DNA-Binding Proteins | 6 | 1996 | 204 |
Why?
| Androgen Receptor Antagonists | 5 | 2001 | 8 |
Why?
| Anticarcinogenic Agents | 2 | 2003 | 8 |
Why?
| Phosphatidylinositol 3-Kinases | 3 | 2001 | 67 |
Why?
| Breast Neoplasms | 2 | 2009 | 185 |
Why?
| Mice, Inbred C57BL | 12 | 2002 | 318 |
Why?
| Mice, Transgenic | 8 | 2002 | 209 |
Why?
| Immunohistochemistry | 8 | 2002 | 355 |
Why?
| Fertility | 4 | 2006 | 32 |
Why?
| Cell Cycle Proteins | 2 | 2003 | 71 |
Why?
| Mammary Glands, Animal | 1 | 2003 | 14 |
Why?
| COS Cells | 9 | 2002 | 73 |
Why?
| Transfection | 16 | 1994 | 237 |
Why?
| Gene Expression | 8 | 1994 | 291 |
Why?
| Repressor Proteins | 2 | 1998 | 96 |
Why?
| Gonadal Steroid Hormones | 2 | 1998 | 30 |
Why?
| Cell Death | 2 | 2000 | 94 |
Why?
| BRCA1 Protein | 1 | 2000 | 3 |
Why?
| Cercopithecus aethiops | 6 | 2002 | 67 |
Why?
| Dihydrotestosterone | 8 | 1996 | 15 |
Why?
| Cell Survival | 3 | 2004 | 229 |
Why?
| Receptors, Calcitriol | 3 | 2001 | 15 |
Why?
| Receptor, erbB-2 | 2 | 1999 | 25 |
Why?
| RNA, Messenger | 8 | 1994 | 394 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2009 | 35 |
Why?
| Carcinoma, Hepatocellular | 2 | 2008 | 53 |
Why?
| Cloning, Molecular | 8 | 1994 | 183 |
Why?
| Morphogenesis | 3 | 2003 | 47 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 38 |
Why?
| Liver Neoplasms | 2 | 2008 | 97 |
Why?
| Polymerase Chain Reaction | 5 | 1994 | 279 |
Why?
| Phenotype | 5 | 2003 | 303 |
Why?
| Base Sequence | 11 | 1994 | 371 |
Why?
| Leptin | 2 | 2005 | 11 |
Why?
| Adipose Tissue | 3 | 2002 | 80 |
Why?
| Liver | 3 | 2008 | 248 |
Why?
| Insulin Resistance | 2 | 2005 | 37 |
Why?
| Oligospermia | 2 | 2004 | 3 |
Why?
| Female | 19 | 2002 | 1643 |
Why?
| RNA, Neoplasm | 2 | 2004 | 41 |
Why?
| Histone Acetyltransferases | 6 | 1998 | 20 |
Why?
| Cell Line | 11 | 1996 | 375 |
Why?
| Molecular Sequence Data | 11 | 1994 | 404 |
Why?
| Amino Acid Sequence | 9 | 1994 | 319 |
Why?
| Protein Structure, Tertiary | 5 | 2001 | 163 |
Why?
| Down-Regulation | 4 | 2001 | 150 |
Why?
| Amino Acid Motifs | 4 | 2003 | 52 |
Why?
| Nuclear Receptor Coactivator 1 | 5 | 1998 | 6 |
Why?
| Cells, Cultured | 4 | 2007 | 447 |
Why?
| Disease Models, Animal | 5 | 2007 | 349 |
Why?
| Gene Knockout Techniques | 2 | 2011 | 16 |
Why?
| Binding Sites | 5 | 2000 | 213 |
Why?
| Curcumin | 3 | 2007 | 11 |
Why?
| Cell Differentiation | 4 | 2004 | 262 |
Why?
| Fibroblasts | 3 | 2002 | 179 |
Why?
| LIM Domain Proteins | 6 | 1999 | 12 |
Why?
| In Situ Nick-End Labeling | 2 | 2004 | 65 |
Why?
| Neoplasms, Hormone-Dependent | 2 | 2001 | 12 |
Why?
| Epithelium | 2 | 2005 | 101 |
Why?
| Muscle Proteins | 2 | 2003 | 56 |
Why?
| Atrophy | 2 | 2008 | 41 |
Why?
| RNA, Small Interfering | 3 | 2007 | 116 |
Why?
| Protein Binding | 9 | 1998 | 256 |
Why?
| Keratin-8 | 1 | 2011 | 2 |
Why?
| Sperm Count | 2 | 2006 | 10 |
Why?
| Vimentin | 2 | 2006 | 21 |
Why?
| Keratin-5 | 1 | 2011 | 3 |
Why?
| Body Weight | 4 | 2002 | 178 |
Why?
| Two-Hybrid System Techniques | 7 | 2001 | 42 |
Why?
| Blotting, Western | 4 | 2001 | 275 |
Why?
| Response Elements | 2 | 2001 | 40 |
Why?
| Homeodomain Proteins | 2 | 2003 | 53 |
Why?
| Integrases | 3 | 2002 | 36 |
Why?
| Hepatitis B virus | 1 | 2010 | 8 |
Why?
| Gelsolin | 3 | 2003 | 9 |
Why?
| RNA Interference | 2 | 2003 | 75 |
Why?
| Hepatitis B | 1 | 2010 | 18 |
Why?
| Co-Repressor Proteins | 1 | 2010 | 3 |
Why?
| Leydig Cells | 2 | 2002 | 9 |
Why?
| Paired Box Transcription Factors | 1 | 2010 | 10 |
Why?
| DNA Primers | 4 | 1994 | 208 |
Why?
| Germ Cells | 2 | 2006 | 11 |
Why?
| Mutation | 5 | 1995 | 340 |
Why?
| Tissue Array Analysis | 1 | 2009 | 27 |
Why?
| Eye Proteins | 1 | 2010 | 26 |
Why?
| Proto-Oncogene Proteins c-akt | 3 | 2001 | 58 |
Why?
| Antibody Specificity | 1 | 2009 | 71 |
Why?
| Recombinant Fusion Proteins | 6 | 1994 | 189 |
Why?
| Androstenediol | 2 | 1998 | 5 |
Why?
| Sulfonic Acids | 1 | 2009 | 8 |
Why?
| Estradiol | 2 | 1998 | 78 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 1999 | 49 |
Why?
| Sex Characteristics | 3 | 2002 | 85 |
Why?
| Myocytes, Smooth Muscle | 1 | 2011 | 35 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2009 | 27 |
Why?
| Genome, Human | 1 | 2009 | 29 |
Why?
| Cell Growth Processes | 2 | 2004 | 24 |
Why?
| Desmin | 1 | 2008 | 8 |
Why?
| Seminiferous Tubules | 1 | 2008 | 7 |
Why?
| Lymphatic Metastasis | 1 | 2009 | 77 |
Why?
| Gene Knockdown Techniques | 1 | 2008 | 26 |
Why?
| Drug Evaluation, Preclinical | 1 | 2009 | 65 |
Why?
| Estrogens | 1 | 2009 | 45 |
Why?
| Autoimmunity | 1 | 2009 | 27 |
Why?
| Drug Synergism | 1 | 2009 | 104 |
Why?
| Neoplasm Transplantation | 2 | 2004 | 67 |
Why?
| Fatty Liver | 1 | 2008 | 20 |
Why?
| Metabolic Diseases | 1 | 2008 | 14 |
Why?
| Protein-Serine-Threonine Kinases | 4 | 1999 | 105 |
Why?
| RNA, Viral | 1 | 2010 | 91 |
Why?
| Azoospermia | 1 | 2007 | 3 |
Why?
| Administration, Oral | 1 | 2009 | 170 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2008 | 49 |
Why?
| Organ Specificity | 4 | 2004 | 104 |
Why?
| Gene Targeting | 2 | 2002 | 51 |
Why?
| Biological Availability | 1 | 2007 | 36 |
Why?
| Muscular Atrophy, Spinal | 1 | 2007 | 8 |
Why?
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2006 | 7 |
Why?
| Ligands | 6 | 1999 | 116 |
Why?
| Organ Size | 4 | 2006 | 118 |
Why?
| Mutagenesis, Site-Directed | 4 | 1999 | 126 |
Why?
| Intercellular Junctions | 1 | 2006 | 17 |
Why?
| RNA | 1 | 2010 | 126 |
Why?
| Nuclear Proteins | 2 | 1999 | 139 |
Why?
| Models, Biological | 4 | 2001 | 410 |
Why?
| Cell Movement | 2 | 2004 | 163 |
Why?
| Dimerization | 2 | 2002 | 92 |
Why?
| Saccharomyces cerevisiae Proteins | 2 | 1999 | 58 |
Why?
| Transplantation, Heterologous | 1 | 2005 | 57 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 224 |
Why?
| Protein Array Analysis | 1 | 2005 | 13 |
Why?
| Retinoid X Receptors | 2 | 1999 | 18 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2003 | 68 |
Why?
| Receptors, Retinoic Acid | 2 | 1999 | 19 |
Why?
| Middle Aged | 2 | 2008 | 1161 |
Why?
| Dose-Response Relationship, Drug | 1 | 2008 | 431 |
Why?
| MAP Kinase Signaling System | 1 | 2005 | 56 |
Why?
| Plasmids | 5 | 1994 | 122 |
Why?
| Myoblasts | 1 | 2004 | 17 |
Why?
| Receptors, Progesterone | 3 | 1998 | 28 |
Why?
| Spermatogonia | 1 | 2004 | 3 |
Why?
| Cell Nucleus | 5 | 2002 | 169 |
Why?
| Ovarian Follicle | 1 | 2004 | 13 |
Why?
| Cell Culture Techniques | 1 | 2005 | 74 |
Why?
| Cytoskeletal Proteins | 1 | 2005 | 55 |
Why?
| Urinary Bladder Neoplasms | 1 | 2007 | 44 |
Why?
| Microfilament Proteins | 2 | 2001 | 41 |
Why?
| Genes, cdc | 1 | 2004 | 4 |
Why?
| B-Lymphocytes | 1 | 2009 | 134 |
Why?
| Amino Acid Transport Systems | 1 | 2004 | 9 |
Why?
| DNA | 3 | 1995 | 262 |
Why?
| Receptor, IGF Type 1 | 1 | 2003 | 11 |
Why?
| Infertility, Female | 1 | 2004 | 17 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2004 | 42 |
Why?
| Membrane Proteins | 3 | 2001 | 233 |
Why?
| Receptors, Steroid | 2 | 1994 | 18 |
Why?
| E2F Transcription Factors | 1 | 2003 | 4 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2003 | 83 |
Why?
| Peptide Library | 1 | 2003 | 21 |
Why?
| Selenomethionine | 1 | 2003 | 6 |
Why?
| Kinetics | 1 | 2007 | 349 |
Why?
| Lipid Metabolism | 3 | 2005 | 50 |
Why?
| Genitalia, Male | 1 | 2002 | 12 |
Why?
| G1 Phase | 1 | 2003 | 27 |
Why?
| Proto-Oncogene Proteins | 2 | 2001 | 113 |
Why?
| Homozygote | 1 | 2002 | 68 |
Why?
| Muscle, Skeletal | 2 | 2002 | 114 |
Why?
| Selenium | 1 | 2002 | 15 |
Why?
| Heterozygote | 1 | 2002 | 80 |
Why?
| Disease Progression | 3 | 2007 | 244 |
Why?
| Blotting, Northern | 3 | 1994 | 151 |
Why?
| Receptors, Glucocorticoid | 2 | 1998 | 26 |
Why?
| Time Factors | 5 | 2001 | 896 |
Why?
| Proteins | 1 | 2005 | 192 |
Why?
| Genes, Reporter | 4 | 1999 | 111 |
Why?
| Peptide Fragments | 1 | 2003 | 144 |
Why?
| Viral Proteins | 1 | 2002 | 71 |
Why?
| Pregnancy | 2 | 2002 | 455 |
Why?
| Recombinant Proteins | 3 | 1996 | 290 |
Why?
| Protein-Tyrosine Kinases | 1 | 2002 | 77 |
Why?
| Protein Biosynthesis | 1 | 2002 | 113 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2000 | 31 |
Why?
| Cyclins | 1 | 2000 | 28 |
Why?
| Dehydroepiandrosterone | 1 | 1999 | 16 |
Why?
| Transforming Growth Factor beta1 | 2 | 2008 | 43 |
Why?
| Glutathione Transferase | 1 | 2000 | 45 |
Why?
| Antigens, Nuclear | 1 | 1999 | 10 |
Why?
| Tyrphostins | 1 | 1999 | 14 |
Why?
| NF-kappa B | 1 | 2003 | 114 |
Why?
| Chloramphenicol O-Acetyltransferase | 2 | 1994 | 21 |
Why?
| Bone and Bones | 1 | 2002 | 99 |
Why?
| Promoter Regions, Genetic | 2 | 1994 | 188 |
Why?
| Molecular Chaperones | 1 | 1999 | 30 |
Why?
| DNA Helicases | 1 | 1999 | 10 |
Why?
| Nuclear Receptor Coactivator 3 | 1 | 1998 | 4 |
Why?
| Flavonoids | 1 | 1999 | 46 |
Why?
| Diethylstilbestrol | 1 | 1998 | 13 |
Why?
| Phosphorylation | 4 | 1995 | 224 |
Why?
| Nerve Tissue Proteins | 2 | 1994 | 128 |
Why?
| Transforming Growth Factor beta | 1 | 2001 | 99 |
Why?
| Mice, Mutant Strains | 2 | 2004 | 77 |
Why?
| Uterus | 2 | 2004 | 49 |
Why?
| Gene Expression Regulation | 3 | 1995 | 277 |
Why?
| Obesity | 2 | 2008 | 149 |
Why?
| Multigene Family | 1 | 1994 | 52 |
Why?
| Caspase 3 | 2 | 2003 | 56 |
Why?
| Caspases | 2 | 2003 | 58 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2003 | 48 |
Why?
| DNA Repair | 2 | 1999 | 47 |
Why?
| Receptors, Thyroid Hormone | 1 | 1994 | 13 |
Why?
| Cyclic AMP | 1 | 1994 | 89 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2004 | 119 |
Why?
| Microscopy, Fluorescence | 2 | 2002 | 137 |
Why?
| Genes, Dominant | 2 | 2001 | 68 |
Why?
| Enzyme Activation | 2 | 2003 | 177 |
Why?
| Molecular Typing | 1 | 2011 | 3 |
Why?
| Breeding | 1 | 2011 | 5 |
Why?
| Structure-Activity Relationship | 2 | 1999 | 124 |
Why?
| Embryonic Stem Cells | 1 | 2011 | 14 |
Why?
| Aging | 2 | 2005 | 275 |
Why?
| Diethylnitrosamine | 1 | 2010 | 5 |
Why?
| Hep G2 Cells | 1 | 2010 | 9 |
Why?
| Tumor Burden | 1 | 2010 | 12 |
Why?
| Cell Transformation, Viral | 1 | 2010 | 35 |
Why?
| Viral Load | 1 | 2010 | 53 |
Why?
| Mutant Proteins | 1 | 2009 | 20 |
Why?
| Adoptive Transfer | 1 | 2009 | 16 |
Why?
| Immunoglobulins | 1 | 2009 | 54 |
Why?
| Arthritis, Experimental | 1 | 2009 | 15 |
Why?
| Infertility | 1 | 2008 | 10 |
Why?
| Tosyl Compounds | 2 | 1998 | 6 |
Why?
| Anilides | 2 | 1998 | 12 |
Why?
| PPAR alpha | 1 | 2008 | 4 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2008 | 10 |
Why?
| Nitriles | 2 | 1998 | 27 |
Why?
| Gene Library | 2 | 1994 | 50 |
Why?
| Genetic Vectors | 1 | 2011 | 139 |
Why?
| Liver Neoplasms, Experimental | 1 | 2008 | 21 |
Why?
| Body Fat Distribution | 1 | 2008 | 6 |
Why?
| 3T3-L1 Cells | 1 | 2008 | 6 |
Why?
| B-Lymphocyte Subsets | 1 | 2009 | 33 |
Why?
| 17-Hydroxysteroid Dehydrogenases | 1 | 2007 | 4 |
Why?
| Spermatids | 1 | 2007 | 5 |
Why?
| 3-Hydroxysteroid Dehydrogenases | 1 | 2007 | 5 |
Why?
| Models, Animal | 1 | 2008 | 85 |
Why?
| Dietary Fats | 1 | 2008 | 33 |
Why?
| Steroid 17-alpha-Hydroxylase | 1 | 2007 | 5 |
Why?
| Genes, p53 | 1 | 2008 | 43 |
Why?
| Epididymis | 1 | 2007 | 12 |
Why?
| Hepatocytes | 1 | 2008 | 42 |
Why?
| Homeostasis | 1 | 2009 | 99 |
Why?
| Drug Delivery Systems | 1 | 2008 | 55 |
Why?
| Threonine | 1 | 2007 | 27 |
Why?
| Neoplasm Metastasis | 1 | 2008 | 112 |
Why?
| Energy Metabolism | 1 | 2008 | 80 |
Why?
| Lipids | 1 | 2008 | 97 |
Why?
| Protein Conformation | 2 | 1998 | 123 |
Why?
| DNA Damage | 1 | 2008 | 66 |
Why?
| Basement Membrane | 1 | 2006 | 31 |
Why?
| 3T3 Cells | 1 | 2006 | 54 |
Why?
| Follicle Stimulating Hormone | 1 | 2006 | 36 |
Why?
| Embryo, Mammalian | 1 | 2008 | 99 |
Why?
| Oxidation-Reduction | 1 | 2008 | 124 |
Why?
| Luteinizing Hormone | 1 | 2006 | 33 |
Why?
| Laminin | 1 | 2006 | 40 |
Why?
| Tumor Markers, Biological | 1 | 2009 | 112 |
Why?
| Glucose | 1 | 2008 | 120 |
Why?
| Reactive Oxygen Species | 1 | 2008 | 112 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 64 |
Why?
| Genotype | 1 | 2006 | 175 |
Why?
| Saccharomyces cerevisiae | 2 | 1999 | 67 |
Why?
| Caspase 9 | 1 | 2004 | 18 |
Why?
| Muscle Fibers, Slow-Twitch | 1 | 2004 | 6 |
Why?
| Muscle Fibers, Fast-Twitch | 1 | 2004 | 7 |
Why?
| MAP Kinase Kinase 4 | 1 | 2004 | 12 |
Why?
| Superovulation | 1 | 2004 | 4 |
Why?
| Hindlimb | 1 | 2004 | 38 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2004 | 21 |
Why?
| Subcellular Fractions | 1 | 2004 | 67 |
Why?
| Drug Stability | 1 | 2004 | 32 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 26 |
Why?
| Consensus Sequence | 1 | 2004 | 39 |
Why?
| Muscle Fibers, Skeletal | 1 | 2004 | 21 |
Why?
| Oxidative Stress | 1 | 2008 | 119 |
Why?
| Biological Markers | 1 | 2007 | 262 |
Why?
| Gestational Age | 1 | 2005 | 114 |
Why?
| Symporters | 1 | 2004 | 11 |
Why?
| Mice, Inbred Strains | 1 | 2004 | 118 |
Why?
| Fluorescent Antibody Technique | 1 | 2004 | 164 |
Why?
| LIM-Homeodomain Proteins | 1 | 2003 | 10 |
Why?
| Blood Glucose | 1 | 2005 | 99 |
Why?
| Transcription Factor RelA | 1 | 2003 | 36 |
Why?
| Endocrine System | 1 | 2003 | 9 |
Why?
| Gene Silencing | 1 | 2003 | 32 |
Why?
| DNA, Neoplasm | 1 | 2003 | 75 |
Why?
| Up-Regulation | 1 | 2004 | 183 |
Why?
| Peptides | 1 | 2004 | 154 |
Why?
| Focal Adhesion Kinase 2 | 1 | 2002 | 7 |
Why?
| Precipitin Tests | 1 | 2002 | 81 |
Why?
| Treatment Outcome | 1 | 2010 | 661 |
Why?
| Chromones | 1 | 2001 | 22 |
Why?
| Morpholines | 1 | 2001 | 28 |
Why?
| ran GTP-Binding Protein | 1 | 2001 | 8 |
Why?
| Lysine | 1 | 2001 | 47 |
Why?
| Serine | 1 | 2001 | 62 |
Why?
| Acetyltransferases | 1 | 2001 | 17 |
Why?
| Smad3 Protein | 1 | 2001 | 26 |
Why?
| Amino Acid Substitution | 1 | 2001 | 68 |
Why?
| Sequence Homology, Amino Acid | 1 | 2001 | 156 |
Why?
| Point Mutation | 1 | 2001 | 122 |
Why?
| DNA-Activated Protein Kinase | 1 | 1999 | 3 |
Why?
| Clusterin | 1 | 1999 | 6 |
Why?
| DNA Probes | 1 | 1999 | 61 |
Why?
| Androstane-3,17-diol | 1 | 1998 | 4 |
Why?
| Luciferases | 1 | 1999 | 70 |
Why?
| Cyproterone Acetate | 1 | 1998 | 3 |
Why?
| Enzyme Inhibitors | 1 | 2001 | 216 |
Why?
| Molecular Weight | 1 | 1999 | 154 |
Why?
| Sequence Analysis, DNA | 1 | 1999 | 110 |
Why?
| Sequence Alignment | 1 | 1999 | 114 |
Why?
| Steroids | 1 | 1998 | 38 |
Why?
| Imidazoles | 1 | 1998 | 47 |
Why?
| Drug Interactions | 1 | 1998 | 111 |
Why?
| Mifepristone | 1 | 1998 | 30 |
Why?
| Glycoproteins | 1 | 1999 | 113 |
Why?
| Rats | 2 | 1994 | 530 |
Why?
| Terminator Regions, Genetic | 1 | 1994 | 7 |
Why?
| Sequence Homology | 1 | 1994 | 12 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1994 | 88 |
Why?
| Rats, Wistar | 1 | 1994 | 75 |
Why?
| Hypothalamus | 1 | 1994 | 33 |
Why?
| Open Reading Frames | 1 | 1994 | 56 |
Why?
| Bucladesine | 1 | 1994 | 31 |
Why?
| Forecasting | 1 | 1995 | 147 |
Why?
| Phylogeny | 1 | 1994 | 63 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 48 |
Why?
| DNA, Complementary | 1 | 1994 | 139 |
Why?
| HeLa Cells | 1 | 1994 | 107 |
Why?
|
|
Yeh's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
